» Articles » PMID: 27479905

Transcription Factors As Readers and Effectors of DNA Methylation

Overview
Journal Nat Rev Genet
Specialty Genetics
Date 2016 Aug 2
PMID 27479905
Citations 322
Authors
Affiliations
Soon will be listed here.
Abstract

Recent technological advances have made it possible to decode DNA methylomes at single-base-pair resolution under various physiological conditions. Many aberrant or differentially methylated sites have been discovered, but the mechanisms by which changes in DNA methylation lead to observed phenotypes, such as cancer, remain elusive. The classical view of methylation-mediated protein-DNA interactions is that only proteins with a methyl-CpG binding domain (MBD) can interact with methylated DNA. However, evidence is emerging to suggest that transcription factors lacking a MBD can also interact with methylated DNA. The identification of these proteins and the elucidation of their characteristics and the biological consequences of methylation-dependent transcription factor-DNA interactions are important stepping stones towards a mechanistic understanding of methylation-mediated biological processes, which have crucial implications for human development and disease.

Citing Articles

Dietary polyunsaturated fatty acids affect PPARγ promoter methylation status and regulate the PPARγ/COX2 pathway in some colorectal cancer cell lines.

Babaeenezhad E, Khosravi P, Moradi Sarabi M Genes Nutr. 2025; 20(1):2.

PMID: 40038577 PMC: 11877738. DOI: 10.1186/s12263-025-00764-x.


Prenatal maternal life adversity impacts on learning and memory in offspring: implication to transgenerational epigenetic inheritance.

Adeline Dorothy P, Rajan K Front Neurosci. 2025; 19:1518046.

PMID: 40018363 PMC: 11865043. DOI: 10.3389/fnins.2025.1518046.


The epigenetic landscape of brain metastasis.

Powell A, Watson L, Luzietti L, Prekovic S, Young L, Vareslija D Oncogene. 2025; .

PMID: 40016470 DOI: 10.1038/s41388-025-03315-1.


Interaction of genetic variants and methylation in transcript-level expression regulation in Alzheimer's disease by multi-omics data analysis.

Han S, Cho S, Choi W, Eilbeck K, Coon H, Nho K BMC Genomics. 2025; 26(1):170.

PMID: 39979805 PMC: 11844006. DOI: 10.1186/s12864-025-11362-x.


Interplay between pioneer transcription factors and epigenetic modifiers in cell reprogramming.

Mirizio G, Sampson S, Iwafuchi M Regen Ther. 2025; 28():246-252.

PMID: 39834592 PMC: 11745816. DOI: 10.1016/j.reth.2024.12.014.


References
1.
Krebs A, Dessus-Babus S, Burger L, Schubeler D . High-throughput engineering of a mammalian genome reveals building principles of methylation states at CG rich regions. Elife. 2014; 3:e04094. PMC: 4381937. DOI: 10.7554/eLife.04094. View

2.
Yu D, Ware C, Waterland R, Zhang J, Chen M, Gadkari M . Developmentally programmed 3' CpG island methylation confers tissue- and cell-type-specific transcriptional activation. Mol Cell Biol. 2013; 33(9):1845-58. PMC: 3624169. DOI: 10.1128/MCB.01124-12. View

3.
Liu Y, Toh H, Sasaki H, Zhang X, Cheng X . An atomic model of Zfp57 recognition of CpG methylation within a specific DNA sequence. Genes Dev. 2012; 26(21):2374-9. PMC: 3489995. DOI: 10.1101/gad.202200.112. View

4.
Baylin S . DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol. 2005; 2 Suppl 1:S4-11. DOI: 10.1038/ncponc0354. View

5.
Kinde B, Gabel H, Gilbert C, Griffith E, Greenberg M . Reading the unique DNA methylation landscape of the brain: Non-CpG methylation, hydroxymethylation, and MeCP2. Proc Natl Acad Sci U S A. 2015; 112(22):6800-6. PMC: 4460470. DOI: 10.1073/pnas.1411269112. View